SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-09-006188
Filing Date
2009-02-04
Accepted
2009-02-04 08:01:19
Documents
14
Period of Report
2009-02-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a09-4625_18k.htm 8-K 27026
2 EX-99.1 a09-4625_1ex99d1.htm EX-99.1 35402
3 EX-99.2 a09-4625_1ex99d2.htm EX-99.2 18509
4 GRAPHIC g46251mmi001.jpg GRAPHIC 2987
5 GRAPHIC g46251mmi002.gif GRAPHIC 5356
6 GRAPHIC g46251moi001.gif GRAPHIC 106556
7 GRAPHIC g46251moi002.gif GRAPHIC 187373
8 GRAPHIC g46251moi003.gif GRAPHIC 131675
9 GRAPHIC g46251moi004.gif GRAPHIC 86788
10 GRAPHIC g46251moi005.gif GRAPHIC 84379
11 GRAPHIC g46251moi006.gif GRAPHIC 90001
12 GRAPHIC g46251moi007.gif GRAPHIC 121819
13 GRAPHIC g46251moi008.gif GRAPHIC 110116
14 GRAPHIC g46251moi009.gif GRAPHIC 89961
  Complete submission text file 0001104659-09-006188.txt   1485369
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 09566805
SIC: 2834 Pharmaceutical Preparations